112 related articles for article (PubMed ID: 9070359)
21. Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.
Jarrar YB; Balasmeh AA; Jarrar W
Libyan J Med; 2018 Dec; 13(1):1408381. PubMed ID: 29173142
[TBL] [Abstract][Full Text] [Related]
22. Human N-acetyltransferase 2 (
Lopes MQP; Teixeira RLF; Cabello PH; Nery JAC; Sales AM; Nahn J R EP; Moreira MV; Stahlke EVR; Possuelo LG; Rossetti MLR; Rabahi MF; Silva LFM; Leme PA; Woods WJ; Nobre ML; de Oliveira MLW; Narahashi K; Cavalcanti M; Suffys PN; Boukouvala S; Gallo MEN; Santos AR
Front Pharmacol; 2023; 14():1278720. PubMed ID: 38035025
[No Abstract] [Full Text] [Related]
23. Function and expression of N-acetyltransferases 1 and 2 are altered in lymphocytes in type 2 diabetes and obesity.
Paz-Rodríguez VA; Herrera-Vargas DJ; Turiján-Espinoza E; Martínez-Leija ME; Rivera-López E; Hernández-González O; Zavala-Reyes D; García-Hernández MH; Vargas-Morales JM; Milán-Segovia RDC; Portales-Pérez DP
Biochem Biophys Rep; 2024 Jul; 38():101716. PubMed ID: 38737726
[TBL] [Abstract][Full Text] [Related]
24. Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity.
Alfirevic A; Stalford AC; Vilar FJ; Wilkins EG; Park BK; Pirmohamed M
Br J Clin Pharmacol; 2003 Feb; 55(2):158-65. PubMed ID: 12580987
[TBL] [Abstract][Full Text] [Related]
25. No association between variant N-acetyltransferase genes, cigarette smoking and Prostate Cancer susceptibility among men of African descent.
Kidd LC; Vancleave TT; Doll MA; Srivastava DS; Thacker B; Komolafe O; Pihur V; Brock GN; Hein DW
Biomark Cancer; 2011 Feb; 2011(3):1-13. PubMed ID: 21709725
[TBL] [Abstract][Full Text] [Related]
26. Arylamine N-acetyltransferases: covalent modification and inactivation of hamster NAT1 by bromoacetamido derivatives of aniline and 2-aminofluorene.
Guo Z; Vath GM; Wagner CR; Hanna PE
J Protein Chem; 2003 Nov; 22(7-8):631-42. PubMed ID: 14714730
[TBL] [Abstract][Full Text] [Related]
27. Critical Roles of Translation Initiation and RNA Uridylation in Endogenous Retroviral Expression and Neural Differentiation in Pluripotent Stem Cells.
Takahashi K; Jeong D; Wang S; Narita M; Jin X; Iwasaki M; Perli SD; Conklin BR; Yamanaka S
Cell Rep; 2020 Jun; 31(9):107715. PubMed ID: 32492424
[TBL] [Abstract][Full Text] [Related]
28. Regioselective O-acetylation of various glucosides catalyzed by Escherichia coli maltose O-acetyltransferase.
Li Y; Wang X; Liu Z; Yang Y; Jiang L; Qu X; Pu X; Luo Y
Appl Microbiol Biotechnol; 2023 Dec; 107(23):7031-7042. PubMed ID: 37728626
[TBL] [Abstract][Full Text] [Related]
29. Corrected speciation and gyromitrin content of false morels linked to ALS patients with mostly slow-acetylator phenotypes.
Lagrange E; Loriot MA; Chaudhary NK; Schultz P; Dirks AC; Guissart C; James TY; Vernoux JP; Camu W; Tripathi A; Spencer PS
eNeurologicalSci; 2024 Jun; 35():100502. PubMed ID: 38770222
[TBL] [Abstract][Full Text] [Related]
30. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Hein DW; Doll MA
Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the Liver.
Francis S; Laurieri N; Nwokocha C; Delgoda R
Sci Rep; 2016 May; 6():26906. PubMed ID: 27242013
[TBL] [Abstract][Full Text] [Related]
32. Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.
Stepp MW; Mamaliga G; Doll MA; States JC; Hein DW
Biochem Biophys Rep; 2015 Sep; 3():45-50. PubMed ID: 26309907
[TBL] [Abstract][Full Text] [Related]
33. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
[TBL] [Abstract][Full Text] [Related]
34. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
Sim E; Abuhammad A; Ryan A
Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
[TBL] [Abstract][Full Text] [Related]
35. Arylamine N-acetyltransferases: a structural perspective.
Zhou X; Ma Z; Dong D; Wu B
Br J Pharmacol; 2013 Jun; 169(4):748-60. PubMed ID: 23517104
[TBL] [Abstract][Full Text] [Related]
36. N-acetyltransferase 2 activity and folate levels.
Cao W; Strnatka D; McQueen CA; Hunter RJ; Erickson RP
Life Sci; 2010 Jan; 86(3-4):103-6. PubMed ID: 19932120
[TBL] [Abstract][Full Text] [Related]
37. Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat.
Barker DF; Walraven JM; Ristagno EH; Doll MA; States JC; Hein DW
Drug Metab Dispos; 2008 Dec; 36(12):2445-51. PubMed ID: 18799802
[TBL] [Abstract][Full Text] [Related]
38. N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice.
Loehle JA; Cornish V; Wakefield L; Doll MA; Neale JR; Zang Y; Sim E; Hein DW
J Pharmacol Exp Ther; 2006 Nov; 319(2):724-8. PubMed ID: 16857729
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.
Sandy J; Mushtaq A; Holton SJ; Schartau P; Noble ME; Sim E
Biochem J; 2005 Aug; 390(Pt 1):115-23. PubMed ID: 15869465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
